Page last updated: 2024-08-23

paclitaxel and Allergic Reaction

paclitaxel has been researched along with Allergic Reaction in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (30.00)29.6817
2010's6 (30.00)24.3611
2020's8 (40.00)2.80

Authors

AuthorsStudies
Banerji, A; Blumenthal, KG; Cogan, AS; McMahon, AE; Robinson, LB; Saff, RR; Wolfson, AR1
Aicher, SA; Blum, C; Hamity, MV; Hammond, DL; Hegarty, DM; Kolker, SJ; Langmack, L1
Ichikawa, G; Nakanishi, K; Okazaki, S; Suzuki, S1
Ahuja, A; Khurana, A; Rani, S; Sachdeva, S; Sardana, K; Savitha, B1
Abelé, M; Aelbrecht-Meurisse, C; Carnot, A; Feutry, F; Gaboriau, L; Le Deley, MC; Léguillette, C; Marliot, G; Sakji, I; Strobbe, G; Villain, A1
Akbarali, HI; Damaj, MI; Jessup, D; Thakker, S; Woods, K1
Cheng, MH; Chou, PL; Fang, YP; Huang, YP; Rau, KM1
Cannita, K; Cocciolone, V; Cortellini, A; Ficorella, C; Lanfiuti Baldi, P; Palluzzi, E; Parisi, A; Porzio, G; Sidoni, T1
Alexandre, J; Emile, G; Gataa, I; Goldwasser, F; Loriot, MA1
Ladich, E; Nakazawa, G; Virmani, R1
Goudevenos, JA; Kounis, NG1
Giannopoulos, S; Goudevenos, JA; Kounis, NG1
Guo, RF; Jin, DJ; Liu, YL; Wang, RY; Xia, XJ; Zhang, PX; Zhou, CP1
Ishii, T; Kawashima, T; Kouyama, Y; Masaka, T; Matsuzawa, Y; Muto, S; Okuno, H; Shirai, K; Yokoyama, Y1
Chen, W; Cheng, G; Du, Y; Fu, F; Tian, J; Wang, H; Wang, T; Ye, L; Zhang, L1
Goromaru, T; Hirakawa, T; Ishida, M; Itoh, Y; Nakano, H; Oishi, R; Sendo, T1
Farb, A; Guagliumi, G; Kolodgie, FD; Virmani, R1
Azarbal, B; Currier, JW1
Duchateau, J; Jaziri, M; Vanhaelen, M; Vanhaelen-Fastré, R1

Reviews

2 review(s) available for paclitaxel and Allergic Reaction

ArticleYear
Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis.
    International journal of nanomedicine, 2020, Volume: 15

    Topics: Drug Delivery Systems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypersensitivity; Male; Middle Aged; Nanoparticles; Network Meta-Analysis; Paclitaxel

2020
Drug-eluting stents: caution and concerns for long-term outcome.
    Coronary artery disease, 2004, Volume: 15, Issue:6

    Topics: Animals; Coronary Restenosis; Device Approval; Humans; Hypersensitivity; Immunosuppressive Agents; Paclitaxel; Polymers; Sirolimus; Stents; Thrombosis; United States; Wound Healing

2004

Trials

1 trial(s) available for paclitaxel and Allergic Reaction

ArticleYear
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:1

    Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Follow-Up Studies; Humans; Hypersensitivity; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Solvents; Taxoids

2020

Other Studies

17 other study(ies) available for paclitaxel and Allergic Reaction

ArticleYear
COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy.
    Allergy, 2022, Volume: 77, Issue:3

    Topics: COVID-19; COVID-19 Vaccines; Docetaxel; Humans; Hypersensitivity; Paclitaxel; SARS-CoV-2

2022
Nicotinamide Riboside Alleviates Corneal and Somatic Hypersensitivity Induced by Paclitaxel in Male Rats.
    Investigative ophthalmology & visual science, 2022, 01-03, Volume: 63, Issue:1

    Topics: Animals; Corneal Diseases; Disease Models, Animal; Hypersensitivity; Male; Niacinamide; Paclitaxel; Rats; Rats, Sprague-Dawley; Tears; Vitamin B Complex

2022
Allergy testing for Cremophor in a patient with cervical cancer with infusion reactions to paclitaxel and docetaxel.
    BMJ case reports, 2022, Jun-24, Volume: 15, Issue:6

    Topics: Docetaxel; Female; Humans; Hypersensitivity; Paclitaxel; Polyethylene Glycols; Taxoids; Uterine Cervical Neoplasms

2022
Case Report: Chemoradiation with Paclitaxel and Carboplatin Unveiling Leprosy Type 1 Downgrading Reaction.
    The American journal of tropical medicine and hygiene, 2022, 07-13, Volume: 107, Issue:1

    Topics: Carboplatin; Humans; Hypersensitivity; Leprosy; Paclitaxel; Peripheral Nervous System Diseases

2022
Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study).
    European journal of clinical pharmacology, 2023, Volume: 79, Issue:9

    Topics: Antineoplastic Agents, Phytogenic; Dexamethasone; Drug Hypersensitivity; Histamine; Histamine Antagonists; Humans; Hypersensitivity; Incidence; Paclitaxel; Premedication; Ranitidine; Retrospective Studies

2023
Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity.
    Scientific reports, 2023, 10-18, Volume: 13, Issue:1

    Topics: Analgesics, Opioid; Animals; Butyrates; Ganglia, Spinal; Hyperalgesia; Hypersensitivity; Mice; Morphine; Nociception; Paclitaxel; Quality of Life

2023
Association between high antitumor activity of oxaliplatin and cyclophosphamide and constitutional GSTM1 homozygous deletion in an advanced ovarian cancer patient.
    Chemotherapy, 2013, Volume: 59, Issue:4

    Topics: Alleles; Antineoplastic Agents; Carboplatin; Cyclophosphamide; Female; Gene Deletion; Glutathione Transferase; Homozygote; Humans; Hypersensitivity; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Recurrence

2013
Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire international, 2009, Volume: 18, Issue:100

    Topics: Angina, Unstable; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sirolimus; Thrombosis; Ticlopidine; Treatment Outcome

2009
Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet....
    Clinical pharmacology and therapeutics, 2009, Volume: 86, Issue:2

    Topics: Alloys; Cardiovascular Agents; Clinical Trials as Topic; Coronary Restenosis; Drug-Eluting Stents; Humans; Hypersensitivity; Incidence; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Sirolimus; Thrombosis; Time Factors

2009
Everolimus-eluting versus paclitaxel-eluting stents.
    Lancet (London, England), 2010, Apr-03, Volume: 375, Issue:9721

    Topics: Drug-Eluting Stents; Equipment Design; Everolimus; Humans; Hypersensitivity; Immunosuppressive Agents; Nickel; Paclitaxel; Sirolimus; Thrombosis

2010
The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, Dec-01, Volume: 76, Issue:7

    Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Drug-Eluting Stents; Everolimus; Humans; Hypersensitivity; Myocardial Infarction; Paclitaxel; Prosthesis Design; Sirolimus; Syndrome; Thrombosis; Treatment Outcome

2010
Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.
    Chemical & pharmaceutical bulletin, 2011, Volume: 59, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholesterol; Drug Carriers; Drug Stability; Emulsions; Glycerol; Guinea Pigs; Hydrogen-Ion Concentration; Hypersensitivity; Injections, Intravenous; Osmolar Concentration; Paclitaxel; Particle Size; Plant Lectins; Poloxamer; Soybean Oil; Soybean Proteins; Triglycerides

2011
Development of an enzyme-linked immunosorbent assay system to determine the presence of antibodies specific for taxane structures.
    Biological & pharmaceutical bulletin, 2011, Volume: 34, Issue:4

    Topics: Animals; Antibodies; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Cattle; Enzyme-Linked Immunosorbent Assay; Fungi; Humans; Hypersensitivity; Mice; Neoplasms; Paclitaxel; Phytotherapy; Risk Factors; Taxoids; Taxus

2011
Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation.
    Molecular medicine reports, 2013, Volume: 7, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Castor Oil; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Complement Activation; Complement Membrane Attack Complex; Complement System Proteins; Enzyme-Linked Immunosorbent Assay; Histamine; Humans; Hypersensitivity; Liposomes; Lung; Mice; Neoplasms; Paclitaxel

2013
Role of substance P in hypersensitivity reactions induced by paclitaxel, an anticancer agent.
    Peptides, 2004, Volume: 25, Issue:7

    Topics: Animals; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Female; Histamine; Humans; Hypersensitivity; Indoles; Male; Neurokinin-1 Receptor Antagonists; Ovarian Neoplasms; Paclitaxel; Piperidines; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Retrospective Studies; Substance P

2004
Allergic reactions after the implantation of drug-eluting stents: is it the pill or the polymer?
    Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1

    Topics: Coronary Vessels; Drug Hypersensitivity; Humans; Hypersensitivity; Paclitaxel; Sirolimus; Stents

2006
Taxanes in Taxus baccata pollen: cardiotoxicity and/or allergenicity?
    Planta medica, 2002, Volume: 68, Issue:1

    Topics: Alkaloids; Animals; Antibodies, Anti-Idiotypic; Antineoplastic Agents, Phytogenic; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Assay; Humans; Hypersensitivity; Immunoglobulin G; Male; Mice; Paclitaxel; Plant Extracts; Plant Leaves; Pollen; Taxoids; Taxus; Toxicity Tests, Acute

2002